About
Alkaline Phosphatase
Areas of Focus
Categories
Small Molecule Pharmaceutical
Team (6)
Clinical Trials (12)
View allTotal Trials
12
As Lead Sponsor
12
As Collaborator
0
Total Enrollment
1,397
By Phase
PHASE2: 5PHASE1/PHASE2: 5PHASE1: 1PHASE3: 1
By Status
COMPLETED: 6WITHDRAWN: 3TERMINATED: 2ACTIVE_NOT_RECRUITING: 1
Clinical Trials Pipeline12 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2003
2004
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
Hover over trial bars to see details
Recent Trials
NCT06168799Lead Sponsor
Ilofotase Alfa for Prevention of Renal Damage After Cardiac Surgery
PHASE2Active, not recruiting
271 participants
Started: Dec 19, 2023 · Completed: Nov 30, 2025
NCT05890794Lead Sponsor
Pilot Trial of Single Dose Ilofotase Alfa in Hypophosphatasia
PHASE1/PHASE2Completed
12 participants
Started: May 15, 2023 · Completed: Jul 12, 2023
NCT04923282Lead Sponsor
Recombinant Human Alkaline Phosphatase in Healthy Japanese Subjects
PHASE1Completed
34 participants
Started: May 7, 2021 · Completed: Dec 31, 2021
NCT04411472Lead Sponsor
(Revival) Study to Investigate the Efficacy and Safety of Alkaline Phosphatase in Patients With Sepsis-Associated AKI
PHASE3Terminated
676 participants
Started: Nov 2, 2020 · Completed: Aug 18, 2022
NCT02182440Lead Sponsor
A Safety, Tolerability, Efficacy and QoL Study of Human recAP in the Treatment of Patients With SA-AKI
PHASE2Completed
301 participants
Started: Dec 18, 2014 · Completed: Sep 27, 2017
Locations (1)
Headquarters
Utrecht, Netherlands
Map
Loading map...